Hydrocodone/guaifenesin
Jump to navigation
Jump to search
Combination of | |
---|---|
Hydrocodone | Opioid agonist |
Guaifenesin | Expectorant |
Clinical data | |
Trade names | Obredon, Flowtuss, others |
AHFS/Drugs.com | |
License data | |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
KEGG |
Hydrocodone/guaifenesin, sold under the brand name Obredon among others, is a fixed-dose combination medication used for the treatment of cough.[2] It contains hydrocodone, as the bitartrate, an opioid agonist; and guaifenesin, an expectorant.[2] It is taken by mouth.[2]
Hydrocodone/guaifenesin was approved for medical use in the United States in 2014.[3][4]
Adverse effects
In the US, the label for hydrocodone/guaifenesin contains a black box warning about addiction, abuse, and misuse.[2]
References
- ^ "Flowtuss (hydrocodone bitartrate and guaifenesin) oral solution, CII Initial U.S. Approval: 2014". DailyMed. Retrieved 21 December 2023.
- ^ a b c d e "Obredon- hydrocodone bitartrate and guaifenesin solution". DailyMed. 15 December 2023. Retrieved 21 December 2023.
- ^ "Flowtuss, (hydrocodone bitartrate and guaifenesin), oral solution". U.S. Food and Drug Administration (FDA). 29 February 2016. Retrieved 21 December 2023.
- ^ "Obredon, (hydrocodone/guaifenesin) Oral Solution". U.S. Food and Drug Administration (FDA). 7 April 2015. Retrieved 21 December 2023.
Categories:
- Articles with short description
- Short description is different from Wikidata
- Use American English from December 2023
- All Wikipedia articles written in American English
- Use dmy dates from December 2023
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- Combination drugs
- Expectorants
- All stub articles
- Pharmacology stubs